Amphastar Pharmaceuticals, Inc. (AMPH) Social Stream
AMPHASTAR PHARMACEUTICALS INC (AMPH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AMPHASTAR PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 5 | $25 | $20 | $22.5 | $56.82 | -60.4% |
| 2021-12-30 | 5 | $29 | $20 | $23.75 | $56.82 | -58.2% |
| 2022-01-12 | 4 | $29 | $20 | $25.5 | $56.82 | -55.12% |
| 2022-01-18 | 4 | $33 | $20 | $27.5 | $56.82 | -51.6% |
| 2022-03-11 | 4 | $35 | $33 | $33.666 | $56.82 | -40.75% |
| 2022-05-10 | 4 | $47 | $33 | $41 | $56.82 | -27.84% |
| 2022-05-18 | 4 | $45 | $33 | $40.333 | $56.82 | -29.02% |
| 2022-06-12 | 3 | $45 | $33 | $39 | $56.82 | -31.36% |
| 2022-07-21 | 3 | $45 | $45 | $45 | $56.82 | -20.8% |
| 2022-08-09 | 3 | $45 | $44 | $44.5 | $56.82 | -21.68% |
| 2022-10-21 | 4 | $44 | $36 | $41 | $56.82 | -27.84% |
| 2022-10-25 | 4 | $44 | $36 | $40 | $56.82 | -29.6% |
| 2023-01-17 | 4 | $40 | $36 | $38 | $56.82 | -33.12% |
| 2023-03-01 | 4 | $41 | $36 | $39 | $56.82 | -31.36% |
| 2023-03-02 | 4 | $44 | $40 | $41.666 | $56.82 | -26.67% |
| 2023-04-24 | 4 | $44 | $41 | $43 | $56.82 | -24.32% |
| 2023-05-05 | 3 | $44 | $41 | $43 | $56.82 | -24.32% |
| 2023-05-10 | 3 | $46 | $43 | $44.333 | $56.82 | -21.98% |
| 2023-05-17 | 4 | $46 | $43 | $44.25 | $56.82 | -22.12% |
| 2023-06-15 | 4 | $55 | $44 | $47.25 | $56.82 | -16.84% |
| 2023-06-26 | 4 | $55 | $44 | $49.5 | $56.82 | -12.88% |
| 2023-07-18 | 4 | $66 | $44 | $52.25 | $56.82 | -8.04% |
| 2023-07-24 | 4 | $66 | $44 | $54 | $56.82 | -4.96% |
| 2023-07-25 | 4 | $70 | $44 | $60.5 | $56.82 | 6.48% |
| 2023-11-09 | 4 | $71 | $44 | $62.75 | $56.82 | 10.44% |
| 2023-11-13 | 4 | $71 | $44 | $61.75 | $56.82 | 8.68% |
| 2023-12-01 | 5 | $71 | $44 | $62 | $56.82 | 9.12% |
The Trend in the Analyst Price Target
AMPH's average price target has moved up $31.75 over the prior 21 months.
AMPH reports an average of 5.45% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-17 | 4 | 40 | 36 | 38.00 | 28.95 | 31.26% |
| 2023-03-01 | 4 | 41 | 36 | 39.00 | 36.56 | 6.67% |
| 2023-04-24 | 4 | 44 | 41 | 43.00 | 40.91 | 5.11% |
| 2023-08-09 | 4 | 71 | 44 | 62.75 | 62.21 | 0.87% |
| 2023-11-13 | 5 | 71 | 44 | 61.75 | 53.55 | 15.31% |
AMPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 35 weeks, AMPH's average broker recommendation rating worsened by 0.3.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMPH as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, AMPHASTAR PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 351.94% of them.
- In terms of how AMPHASTAR PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 380.94% of that group.
- AMPHASTAR PHARMACEUTICALS INC's variance in analysts' estimates is lower than -352.73% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, AMPHASTAR PHARMACEUTICALS INC's average analyst price target is greater than 2027.01% of them.
Stocks similar to AMPHASTAR PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FGEN, TARO, and ITCI.
View All Top Stocks by Price Target
Make investment decisions regarding AMPH using the data that counts. Try POWR Ratings for free.